2054-619x

EMJ Oncology

European Medical Group

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 193 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact193 DOIs
2

Add license metadata to 193 records

License metadata tells indexers and readers how each article may be reused.

High impact193 DOIs
3

Deposit reference lists for 62 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact62 DOIs

DOIs for this ISSN

Showing the top 5 of 192 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Symptoms and Quality of Life in Gastroenteropancreatic Neuro… (10.33590/emjoncol/10313153)
References ORCID License
71.57 8
2 Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lym… (10.33590/emjoncol/10314554)
References ORCID License
67.73 7
3 Field Cancerisation of the Upper Aerodigestive Tract: Screen… (10.33590/emjoncol/10313755)
References ORCID License
63.38 6
4 Muscle Dysfunction in Childhood Cancer: Biological Mechanism… (10.33590/emjoncol/10310846)
ORCID License
55.70 12
5 Yoga as Treatment for Insomnia Among Cancer Patients and Sur… (10.33590/emjoncol/10311931)
References ORCID License
52.42 4
6 The Importance of Mutational Analysis in Chronic Myeloid Leu… (10.33590/emjoncol/10311536)
ORCID License
47.71 8
7 New Cervical Cancer Screening Guidelines on Both Sides of th… (10.33590/emjoncol/10310984)
References ORCID License
35.78 2
8 Elacestrant Monotherapy as a Second-Line Treatment for ER-Po… (10.33590/emjoncol/heyq8042)
Abstract ORCID License
35.78 2
9 A Review of Gene Expression Profiling in Early-Stage ER+/HER… (10.33590/emjoncol/10311156)
ORCID License
34.95 4
10 A Review of the Latest Advancements in Ovarian Cancer Care F… (10.33590/emjoncol/10300067)
ORCID License
30.10 3
11 Epithelial Myoepithelial Carcinoma of the Hard Palate: A Cas… (10.33590/emjoncol/10313538)
ORCID License
30.10 3
12 Understanding the Microenvironment of Melanoma Cells for the… (10.33590/emjoncol/10314408)
ORCID License
30.10 3
13 Advancements in Endometrial Cancer Research in 2023 (10.33590/emjoncol/11000026)
ORCID License
30.10 3
14 Recent Developments in Endometrial Cancer Research Presented… (10.33590/emjoncol/10302519)
ORCID License
23.86 2
15 Improving Inclusivity, Equity, and Diversity in Oncology Cli… (10.33590/emjoncol/10303428)
ORCID License
23.86 2
16 microRNAS in Therapy Resistance of Breast Cancer (10.33590/emjoncol/10311296)
ORCID License
23.86 2
17 Optimised Tumour Sampling and Processing by a Multidisciplin… (10.33590/emjoncol/10311320)
ORCID License
23.86 2
18 Simple, Low-Cost, and Timely Optical Biosensors for the Dete… (10.33590/emjoncol/10311704)
ORCID License
23.86 2
19 Gastrointestinal Stromal Tumours: A Review on Genetics, Path… (10.33590/emjoncol/10312824)
ORCID License
23.86 2
20 More than FOLFOX and FOLFIRI: The Management of Metastatic C… (10.33590/emjoncol/21-00122)
ORCID License
23.86 2
21 Thyroid Papillary Carcinoma and Hyperthyroidism: A Case Stud… (10.33590/emjoncol/21-00176)
ORCID License
23.86 2
22 Updates in BRAF V600E-Mutated Metastatic Colorectal Cancer (10.33590/emjoncol/jdxk9403)
ORCID License
23.86 2
23 Advancements in Endometrial Cancer Research in 2024 (10.33590/emjoncol/ninn2044)
ORCID License
23.86 2
24 Immunotherapeutic Strategies Based on CAR-T Cells in Hepatoc… (10.33590/emjoncol/tabt3057)
ORCID License
23.86 2
25 Alloimmune Thrombocytopaenic Disorders: A Review (10.33590/emjoncol/10310519)
References ORCID License
22.58 1
26 Development of Drugs Targeting the PI3K Signalling Pathway i… (10.33590/emjoncol/10310766)
References ORCID License
22.58 1
27 Sequential Androgen Receptor Pathway Inhibitor in Prostate C… (10.33590/emjoncol/10311857)
References ORCID License
22.58 1
28 Role of Positron Emission Tomography with Fluorodeoxyglucose… (10.33590/emjoncol/10312041)
References ORCID License
22.58 1
29 Management of Patients with High-Grade Glioma (10.33590/emjoncol/10312293)
References ORCID License
22.58 1
30 Intensity-Modulated Radiotherapy in the Treatment of Pancrea… (10.33590/emjoncol/10312445)
References ORCID License
22.58 1
31 Paradigm Shift in the Management of Gynaecological Cancers (10.33590/emjoncol/10312687)
References ORCID License
22.58 1
32 Checkpoint Blockade in Cancer Immunotherapy: Squaring the Ci… (10.33590/emjoncol/10314057)
References ORCID License
22.58 1
33 Precision Medicine in Lung Cancer (10.33590/emjoncol/19-00145)
Abstract ORCID License
22.58 1
34 Ewing’s Sarcoma of the Lung as a Second Malignancy in Long-T… (10.33590/emj/21-00201)
ORCID License
15.05 1
35 The Role of Radical Radiotherapy in Sinonasal Myopericytoma:… (10.33590/emjoncol/10049168)
ORCID License
15.05 1
36 Acquired PTEN Loss May Mediate Dabrafenib and Trametinib Res… (10.33590/emjoncol/10305035)
ORCID License
15.05 1
37 The Plate Matters: Exploring the Intersection of Food Insecu… (10.33590/emjoncol/10306925)
ORCID License
15.05 1
38 Real-World Evidence of Biosimilar Utilisation and Pharmacoec… (10.33590/emjoncol/10307863)
ORCID License
15.05 1
39 The Importance of the Multidisciplinary Team in the Manageme… (10.33590/emjoncol/10309426)
ORCID License
15.05 1
40 Recent Advances in the Treatment of Metastatic Soft Tissue S… (10.33590/emjoncol/10310137)
ORCID License
15.05 1
41 Chemotherapy for Extracranial Germ Cell Tumours in Paediatri… (10.33590/emjoncol/10310463)
ORCID License
15.05 1
42 PARP Inhibitors as a Novel Treatment Strategy for Patients w… (10.33590/emjoncol/10310504)
ORCID License
15.05 1
43 Optimising Salvage Therapy in Aggressive B Cell Non-Hodgkin… (10.33590/emjoncol/10311655)
ORCID License
15.05 1
44 Modern Indications for Endoscopic Endonasal Surgery (10.33590/emjoncol/10314593)
ORCID License
15.05 1
45 From Traditional Histology to Next-Generation Pathology: A R… (10.33590/emjoncol/19-00107)
ORCID License
15.05 1
46 Phosphate and Oxysterols May Mediate an Inverse Relationship… (10.33590/emjoncol/20-00067)
ORCID License
15.05 1
47 Management of Lower Limb Soft Tissue Sarcomas with Major Neu… (10.33590/emjoncol/20-00084)
ORCID License
15.05 1
48 Nasopharyngeal Rhabdomyosarcoma: A Rare Malignancy Incidenta… (10.33590/emjoncol/20-00126)
ORCID License
15.05 1
49 Balancing Risk of Thromboembolism and Bleeding in Patients w… (10.33590/emjoncol/21-00002)
ORCID License
15.05 1
50 Effectiveness of Vinorelbine in the Management of Pseudomyog… (10.33590/emjoncol/erte7664)
ORCID License
15.05 1